Harvard Heart Letter

Ask the doctor: Should I try one of the new blood thinners?

Although new blood thinners such as dabigatran (Pradaxa) and rivaroxaban (Xarelto) do not require regular monitoring, people who manage well on warfarin may want to stay on warfarin until additional information on these new drugs becomes available.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »